Target intelligence / Profile preview

Inter-endothelial gap formation

Molecular classification
Biological process, Cellular mechanism
01

Overview

Inter-endothelial gap formation is a fundamental biological process characterized by the physical separation of adjacent endothelial cells, resulting in increased paracellular vascular permeability [Schlegel & Waschke, 2014]. This phenomenon occurs when the forces generated by the endothelial actomyosin cytoskeleton (cell contraction) overcome the adhesive forces of intercellular junctions, primarily the adherens junctions composed of vascular endothelial (VE)-cadherin [Sukriti et al., 2014]. In physiological conditions, controlled gap formation is necessary for the migration of immune cells into tissues; however, its dysregulation is a hallmark of pathological states like sepsis and acute respiratory distress syndrome (ARDS), where massive fluid leakage leads to organ failure [Komarova et al., 2015]. While it is not a single molecular target, it represents the cumulative effect of various signaling cascades, such as the RhoA/ROCK, Myosin Light Chain Kinase (MLCK), and VEGF-mediated pathways. Therapeutic intervention often focuses on stabilizing these junctions or inhibiting the contractile machinery to restore the endothelial barrier [Claesson-Welsh et al., 2021].

Other names
Endothelial gap formationParacellular gap formationEndothelial barrier disruptionVascular leakageEndothelial cell retraction
02

Mechanism of action

Stabilization of endothelial adherens junctions and inhibition of actomyosin-mediated cellular contraction through the modulation of signaling pathways like VEGF, Rho/ROCK, and MLCK.

03

Biological functions

Regulation of vascular permeabilityInflammatory responseLeukocyte transendothelial migrationParacellular transportTissue fluid homeostasis
04

Disease associations

SepsisAcute respiratory distress syndrome (ARDS)Diabetic retinopathyEdemaCancer metastasisAtherosclerosisSystemic inflammatory response syndrome (SIRS)
05

Safety considerations

Impairment of physiological leukocyte extravasation for infection controlDelayed wound healing and tissue repairPotential for systemic hypertensionAlteration of normal organ-specific permeability
06

Interacting drugs

Bevacizumab

6 more in the full profile.

07

Biomarkers

Soluble Vascular Endothelial Cadherin (sVE-cadherin)Angiopoietin-2 (Ang-2)Vascular Endothelial Growth Factor (VEGF) concentrationCirculating endothelial cells (CECs)

Beyond the preview

Go deeper on Inter-endothelial gap formation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inter-endothelial gap formation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call